Browse Category

Investment Analysis News 23 October 2025 - 24 October 2025

Genenta Science Stock Skyrockets on Strategic Gene-Therapy Alliance – Is a $25 Price Target Next?

Genenta Science Stock Skyrockets on Strategic Gene-Therapy Alliance – Is a $25 Price Target Next?

Genenta’s Oct. 24 announcement ignited optimism. According to the official press release, Anemocyte will incorporate Genenta’s clinically validated LVV plasmid DNA platform (originating from Naldini’s research) into its production pipeline investing.com. “By making our clinically validated LVV plasmid DNA technology
Global Technology Trends in June-2025: AI, Quantum, EVs, Space & Beyond

IonQ vs Rigetti Computing vs D-Wave Quantum Stocks on October 23, 2025

Quantum Stocks Soar: U.S. Government Interest Triggers Rally in IonQ, Rigetti, D-Wave Government Talks & Media Reports This week’s frenzy began with a WSJ report that President Trump’s administration was discussing taking ownership stakes in certain quantum computing startups in
Blackstone (BX) Shines With Big Q3 Beat & $18B Hologic Deal – But Why Are Shares Falling?

Blackstone (BX) Shines With Big Q3 Beat & $18B Hologic Deal – But Why Are Shares Falling?

Q3 Earnings and Market Reaction Blackstone’s latest results (for the quarter ended Sept. 30) painted a mixed picture. The firm reported distributable earnings of $1.889 billion ($1.52 per share), up 48% from a year ago and well above the $1.23 forecast reuters.com.
1 133 134 135 136 137 145
Go toTop